9MW3011
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for 9MW3011, covering 2024-12-27 to 2025-05-11. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia Vera [Phase 1]